Article
How U.S. pricing reform is reshaping global market dynamics
Featured at the ISPOR US 2026 Educational Symposium, this session explores how most-favored-nation and international reference pricing models are increasing cross-market pricing interdependencies.
U.S. drug pricing reform is creating stronger links between domestic and international markets.
As most-favored-nation and international reference pricing models gain traction, manufacturers face growing pressure to understand how pricing, reimbursement, launch timing, and access decisions in one market can influence outcomes across many others.
This educational session examines the connection between U.S. policy and global pricing dynamics, highlights the strategic impact of cross-market reference pricing, and outlines key considerations for launch planning, market access, and global coordination.
Click below to explore insights from the session.
This educational session examines the connection between U.S. policy and global pricing dynamics, highlights the strategic impact of cross-market reference pricing, and outlines key considerations for launch planning, market access, and global coordination.
Click below to explore insights from the session.
